Correction: Safety profile of upadacitinib in rheumatoid arthritis: integrated analysis from the SELECT phase III clinical programme. . Ann Rheum Dis 2021;80:e83.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

. Correction: Safety profile of upadacitinib in rheumatoid arthritis: integrated analysis from the SELECT phase III clinical programme. Ann Rheum Dis 2021;80:e83.
PMID: 34412030